Guru Ownership Trend
Guru Analysis for Spero Therapeutics, Inc. (SPRO)
Spero Therapeutics, Inc. (SPRO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.17 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $434,534.73 net outflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 74.9%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 20.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Spero Therapeutics, Inc. (SPRO)
Major holders include Renaissance Technologies (RenTech) ($2.09 M), Steven Cohen ($230,673). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.05 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $434,534.73, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited SPRO. The total reported sell value was $533,341.55.
Yes, 0 managers opened new positions in SPRO, and 1 increased their existing holdings. The total reported buy value was $98,806.82.